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Exploring Vanadium Chemical Transferrin Mimetic Compounds for Insulin
Enhancement
Abstract
Diabetes Mellitus (DM) is caused by a lack of insulin production (Type 1) or the body’s cells’ inability to
properly receive it, also known as insulin resistance (Type 2), resulting in greatly elevated levels of blood
glucose. Vanadium(IV) and vanadium(V) ions are believed to enhance insulin activity by inhibition of
protein tyrosine phosphatase 1B (PTP1B). PTP1B is normally responsible for downregulating the insulin
signaling, but in DM type 2, PTP1B activity is overexpressed leading to the insulin signaling blocking. The
most promising V(IV) compounds are designed for oral delivery: they are absorbed into the gut and
delivered into the bloodstream where they are bound by the iron transporting protein serum transferrin
(sTf). STf delivers the compound into cells via endocytosis, where vanadium can bind PTP1B. A limitation
of these compounds is their poor stability at the stomach acidic conditions in which they undergo a
significant amount of dissociation, resulting in a very inefficient gut absorption. This study explores the
use of a chemical transferrin mimetic (cTfm) ligand to create V(IV) and V(V) compounds featuring
excellent acidic pH stability for improved gut absorption. The cTfm-V(IV,V) compounds are expected to be
labile in the pH of the bloodstream and thus the vanadium species can be quickly ligand exchanged with
sTF. The cTfm ligand N,N'-di(o-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED) was used to
synthesize VO(IV)HBED and VO(V)HBED which demonstrated great aqueous stability in the 1-4 pH range.
The role of citrate as a vehicle for delivering vanadium to sTf to regulate the transport of vanadium is also
examined.
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ABSTRACT
Diabetes Mellitus (DM) is caused by a lack of insulin production (Type 1) or the body’s
cells’ inability to properly receive it, also known as insulin resistance (Type 2), resulting in
greatly elevated levels of blood glucose. Vanadium(IV) and vanadium(V) ions are believed to
enhance insulin activity by inhibition of protein tyrosine phosphatase 1B (PTP1B). PTP1B is
normally responsible for downregulating the insulin signaling, but in DM type 2, PTP1B
activity is overexpressed leading to the insulin signaling blocking. The most promising V(IV)
compounds are designed for oral delivery: they are absorbed into the gut and delivered into the
bloodstream where they are bound by the iron transporting protein serum transferrin (sTf). STf
delivers the compound into cells via endocytosis, where vanadium can bind PTP1B. A
limitation of these compounds is their poor stability at the stomach acidic conditions in which
they undergo a significant amount of dissociation, resulting in a very inefficient gut absorption.
This study explores the use of a chemical transferrin mimetic (cTfm) ligand to create V(IV)
and V(V) compounds featuring excellent acidic pH stability for improved gut absorption. The
cTfm-V(IV,V) compounds are expected to be labile in the pH of the bloodstream and thus the
vanadium species can be quickly ligand exchanged with sTF. The cTfm ligand N,N'-di(ohydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED) was used to synthesize
VO(IV)HBED and VO(V)HBED which demonstrated great aqueous stability in the 1-4 pH
range. The role of citrate as a vehicle for delivering vanadium to sTf to regulate the transport
of vanadium is also examined.
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